GADOTERATE MEGLUMINE

Search structure
Trade Names:
Synonyms:
Status: Approved (2013)
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: L0ND3981AG

Physicochemical Descriptors

Property Name Value
Molecular Formula C23H42GdN5O13
Molecular Weight 753.86
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Pharmacology

Action Mechanism of Action Reference
None Diagnostic agent DailyMed

Indications

Mesh Heading Maximum Phase Reference
Atherosclerosis; Coronary Artery Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Myocardial Ischemia Phase 4 ClinicalTrials
Carcinoma, Hepatocellular Phase 4 ClinicalTrials
Breast Diseases Phase 4 ClinicalTrials

Related Entries

MCS

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Skin and subcutaneous tissue disorders
17.53
Respiratory, thoracic and mediastinal disorders
13.27
Immune system disorders
10.34
Gastrointestinal disorders
9.78
General disorders and administration site conditions
9.78
Nervous system disorders
8.8
Cardiac disorders
7.62
Vascular disorders
5.53
Musculoskeletal and connective tissue disorders
3.33
Injury, poisoning and procedural complications
2.83
Psychiatric disorders
2.54
Eye disorders
2.41

Cross References

Resources Reference
ChEMBL CHEMBL2219415
FDA SRS L0ND3981AG
PubChem 6918037
CONTENTS